Effects Of Sensory Training & Electrical Stimulation on Sole of The Foot

Status Completed

Clinical Trial Summary

The aim of this study is to investigate the effects of the sole of foot sensory education and electrical stimulation on proprioceptive and cortical senses in patients with acute hemiplegia.

Clinical Trial Description

Hemiplegia is a syndrome characterized by disorders of motor and sensory functions, speech and mental abilities. Hemiplegia is a common neurological problem in the world and is the third most common cause of death. In addition to motor loss in patients after stroke, sensory problems are accompanied and close to 60% of stroke patients experience sensory problems. In a limited number of studies in the literature, it is stated that sensory impairment in the lower extremity negatively affects standing, walking speed, balance during ambulation and symmetrical gait. At the same time, it has been proven that the sole of the foot sense plays an important role in the balance of sitting, standing up and performing independent daily living activities. After a stroke, sensory training increases functionality, patients with sensory training recover faster, mobility, balance and daily life activities become better, and daily life improvement is expressed. The purpose of sensory training is to maximize the patient's learning through the connection between environment and repetitive activities. The aim of this study is to compare the effects of neurodevelopmental physiotherapy program combined with sensory training or electrical stimulation on the sole of the foot proprioceptive and cortical senses in individuals diagnosed with hemiplegia. There is no study on how proprioceptive and cortical sensations will be affected in acute hemiplegic patients if sensory training and electrical stimulation are added to the classical treatment program. By finding and comparing the effects of active (sensory training) and passive treatment (electric stimulation) with this study, it was planned to propose an effective treatment protocol for developing the sole of the foot senses to the experts working in this field. As a result, purpose of the study is to prevent inadequate sensory input in hemiplegic patients from adversely affecting quality of life. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04252092
Study type	Interventional
Source	Yeditepe University
Contact
Status	Completed
Phase	N/A
Start date	February 17, 2020
Completion date	August 25, 2020

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05378035` - DOAC in Chinese Patients With Atrial Fibrillation
Completed	`NCT03679637` - Tablet-based Aphasia Therapy in the Acute Phase After Stroke	N/A
Completed	`NCT03574038` - Transcranial Direct Current Stimulation as a Neuroprotection in Acute Stroke	N/A
Completed	`NCT03633422` - Evaluation of Stroke Patient Screening
Completed	`NCT04088578` - VNS-supplemented Motor Retraining After Stroke	N/A
Not yet recruiting	`NCT05534360` - Tenecteplase Treatment in Ischemic Stroke Registry
Withdrawn	`NCT04991038` - Clinical Investigation to Compare Safety and Efficacy of DAISE and Stent Retrievers for Thrombectomy In Acute Ischemic Stroke Patients	N/A
Not yet recruiting	`NCT04105322` - Effects of Kinesio Taping on Balance and Functional Performance in Stroke Patients	N/A
Withdrawn	`NCT05786170` - ERILs Und SNILs Unter SOC	N/A
Recruiting	`NCT03132558` - Contrast Induced Acute Kidney in Patients With Acute Stroke	N/A
Completed	`NCT02893631` - Assessment of Hemostasis Disorders in rtPA-treated Patients Requiring Endovascular Treatment for Ischemic Stroke
Active, not recruiting	`NCT02274727` - Biomarker Signature of Stroke Aetiology Study: The BIOSIGNAL-Study
Completed	`NCT02225730` - Imaging Collaterals in Acute Stroke (iCAS)
Terminated	`NCT01705353` - The Role of HMGB-1 in Chronic Stroke	N/A
Active, not recruiting	`NCT01581502` - SAMURAI-NVAF Study: Anticoagulant Therapy for Japanese Stroke Patients With Nonvalvular Atrial Fibrillation (NVAF)	N/A
Completed	`NCT01182818` - Fabry and Stroke Epidemiological Protocol (FASEP): Risk Factors In Ischemic Stroke Patients With Fabry Disease	N/A
Completed	`NCT00761982` - Autologous Bone Marrow Stem Cells in Middle Cerebral Artery Acute Stroke Treatment.	Phase 1/Phase 2
Completed	`NCT00535197` - Autologous Bone Marrow Stem Cells in Ischemic Stroke.	Phase 1/Phase 2
Terminated	`NCT00132509` - FRALYSE Trial: Comparison of the Classical Rt-PA Procedure With a Longer Procedure in Acute Ischemic Stroke	Phase 2
Recruiting	`NCT05760326` - Diagnostic and Prognostic Role of Clot Analysis in Stroke Patients

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Effects Of Sensory Training and Electrical Stimulation on Sole of The Foot Sensations in Patients With Acute Hemiplegia

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms